Innovative Healthcare Solution Proposal
This proposal outlines a restricted, sensitive healthcare idea addressing a significant problem, providing a solution, and predicting potential impact. It also explores existing market solutions and foresees implementation challenges, detailing past office interactions.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Restricted, Sensitive (Normal) Idea Title: Name Designation, Department Date 1
1. Submission Particulars Name(s) of submitters Is the submitter the lead for this idea / project? Institution Department Email address(es) Contact Number Please provide your ACP (if applicable) Yes / No [highlight as appropriate] 2 2
Please state the background and magnitude of the problem: 1. What is the problem? Describe the background and problem that needs to be solved 2. What s the current work-around and it s limitations? 3. How big is the problem? I.e. Extent of the problem/gap/clinical need? Incidence and /or prevalence? Problem Restricted, Sensitive (Normal) 3
Proposed Idea In this slide, briefly describe the solution to the problem described. Restricted, Sensitive (Normal) 4
Potential Impact In this slide, briefly describe the impact of the problem and solution e.g. no. of healthcare workers / patients affected and how they will benefit. If the innovation is adopted : how many people (staff/patients) would receive services that were changed? What outcome measures could be used to show benefit? You may use the table below Impact Assessment Indicator Remarks List possible measures eg improved patient care/safety: improved PROMs (patient related outcomes measures)/ patient experience/cost and time savings for patients/less adverse events. Estimated Institution or cluster wide or national level Please cite references/ methods as applicable List possible measures eg. Improved healthcare productivity (cost and time savings)/Improved healthcare professional experience Institution or cluster wide or national level Please cite references/methods as applicable Restricted, Sensitive (Normal) 5
Are there any similar solutions in the market currently? Please share your search on: 1. Existing market ready solutions 2. Whether the existing solutions can meet your needs 3. Publication review/tech scan of market ready products Restricted, Sensitive (Normal) 6
In this slide, explain the challenges in the implementation of the proposed idea Foreseeable Challenges Restricted, Sensitive (Normal) 7
Highlight the offices that you have approached regarding this idea. Offices already approached Cluster: Institutional: SGH Organisational Planning & Performance (OPP) CGH Office of Innovation (OOI) Singapore Eye Research Institute (SERI) ALPS Pte Ltd Integrated Health Information Systems (IHiS) Pte Ltd SingHealth: SingHealth Office of Research (OOR) SingHealth Office of Intellectual Property (SHIP) Medical Technology Office (MTO) Office for Service Transformation (OST) Institute of Patient Safety & Quality (IPSQ) Health Services Research Centre (HSRC) Other (please specify): Office of Digital Strategy Office for Innovation GAH Nursing Restricted, Sensitive (Normal) 8
Highlight the stage(s) where your idea is currently at. Progress of Idea Development 1. Beneficiaries and value proposition have been identified. 2. Identified possible partners such as schools/research institutes/companies (please list the identified partners) 3. 4. 5. 6. 7. 8. 9. Some prototype or initial solution has been developed for testing. Prototype / initial solution is in the testing / validation phase. Buy-in from stakeholders has been identified on the testing / validation results. Prototype / initial solution has been refined into a working solution. Working solution has been deployed on a small scale. Solution has been planned for scaling up / adoption. Solution is ready for commercialisation / has been implemented. Restricted, Sensitive (Normal) 9
Expertise needed and queries to address List down the questions you may want to ask a panellist from the areas below. You can also remove expertise types you don t need. Type of Expertise Questions Prototyping Design thinking / quality improvement IP consultancy / market access Procurement Digital solutioning Business case / financials Scaling up / adoption of solution Academic / external partners Other (please specify) Restricted, Sensitive (Normal) 10
Please complete the following for the panellists to better understand the status of your idea / project. Other factors Have you applied for funding and what is the status of application? (Please highlight) Have not applied for funding Require seed funding (up to $25k for prototyping Please complete Annex A - Budget) In process of application (Please specify the name of the grant applied) Approved for funding (Please specify the name of the grant which was awarded) Rejected for funding (If the application was rejected, please share the reasons for rejection) How confident are you of implementing this idea at the moment? (Please highlight) 1: Not at all confident 2: Not very confident 3: Somewhat confident 4: Very confident Restricted, Sensitive (Normal) 11
Annex A - Budget The Innovation Seed Fund offers funding support of up to S$25,000 per proj for ideas which requires early prototyping funding support. If you are intending to submit for funding support, kindly provide a projected estimate of your foreseeable expenses in the table below You should also apply for FY2022 Cycle 2 ACP Programme Funding - Innovation Seed Grant (ISG). Download the application forms here. The closing date for Innovation Seed Grant is 25 Apr 2022. Please refer to your respective ACP Administrators on the internal processes and deadlines. All submissions must be made via ACP. S/N Item Justification Quantity Total Cost (SGD) Restricted, Sensitive (Normal) 12
